These analyses led to the novel conclusion that activation of HDAC4 and the histone methylase EZH2 are mutually exclusive and represent two distinct biologic fates in cancer cells, one related to growth factor signaling and the other related to inflammatory signaling. This evidence concerns the gene EZH2 and cancer.